ARUNJYOTI BIO VENTURES
|
ARUNJYOTI BIO VENTURES Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.56 | 0.27 | 0.33 | 0.51 | 0.21 |
| CEPS(Rs) | 0.10 | 0.05 | 0.06 | 0.09 | 0.04 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 10.22 | 9.66 | 9.39 | 9.06 | 8.55 |
| Tax Rate(%) | 26.00 | 26.00 | 26.00 | 19.24 | - |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 9.52 | -6.83 | 1.75 | 1.78 | 1.14 |
| EBIT Margin(%) | 9.52 | 2.59 | 1.78 | 1.81 | 1.18 |
| Pre Tax Margin(%) | 9.10 | 2.56 | 1.67 | 1.79 | 1.18 |
| PAT Margin (%) | 6.73 | 1.89 | 1.24 | 1.45 | 1.18 |
| Cash Profit Margin (%) | 6.73 | 1.89 | 1.24 | 1.45 | 1.18 |
| Performance Ratios | |||||
| ROA(%) | 0.61 | 1.66 | 1.29 | 1.86 | 0.56 |
| ROE(%) | 5.68 | 2.85 | 3.57 | 5.80 | 2.51 |
| ROCE(%) | 0.91 | 3.91 | 5.14 | 7.27 | 2.38 |
| Asset Turnover(x) | 0.09 | 0.87 | 1.04 | 1.28 | 0.47 |
| Sales/Fixed Asset(x) | - | - | - | - | - |
| Working Capital/Sales(x) | 0.43 | 2.97 | 12.31 | 19.26 | 13.58 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | - | - | - | - | - |
| Receivable days | 139.03 | 146.04 | 149.32 | 125.56 | 337.23 |
| Inventory Days | 186.12 | - | 1.84 | 13.95 | 51.94 |
| Payable days | - | 84.25 | 136.65 | 128.56 | 529.61 |
| Valuation Parameters | |||||
| PER(x) | 321.25 | 92.01 | 20.81 | - | - |
| PCE(x) | 321.27 | 92.03 | 20.81 | - | - |
| Price/Book(x) | 17.74 | 2.59 | 0.73 | - | - |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 40.21 | 1.74 | 0.11 | 0.13 | 0.46 |
| EV/Core EBITDA(x) | 422.36 | 67.07 | 6.24 | 7.19 | 39.23 |
| EV/EBIT(x) | 422.36 | 67.07 | 6.24 | 7.19 | 39.23 |
| EV/CE(x) | 1.94 | 2.47 | 0.13 | 0.16 | 0.31 |
| M Cap / Sales | 21.63 | 1.74 | 0.26 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | -41.59 | -46.11 | -24.57 | 96.61 | 7,883.09 |
| Core EBITDA Growth(%) | 114.33 | -21.45 | -26.02 | 201.70 | 118.48 |
| EBIT Growth(%) | 114.33 | -21.45 | -26.02 | 201.70 | 118.25 |
| PAT Growth(%) | 107.68 | -17.59 | -35.43 | 141.23 | 117.74 |
| EPS Growth(%) | 107.66 | -17.57 | -35.43 | 141.25 | 117.74 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 15.26 | - | - | - | - |
| Current Ratio(x) | 3.64 | 11.67 | 1.16 | 1.09 | 1.07 |
| Quick Ratio(x) | 3.06 | 11.67 | 1.15 | 1.09 | 0.93 |
| Interest Cover(x) | 22.52 | 72.36 | 16.67 | 75.86 | 307.25 |
| Total Debt/Mcap(x) | 0.86 | - | - | - | - |
Compare Financial Ratios of peers of ARUNJYOTI BIO VENTURES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ARUNJYOTI BIO VENTURES | ₹151.0 Cr | 8.6% | 1.5% | 142.7% | Stock Analytics | |
| BAJAJ FINSERV | ₹254,252.0 Cr | 1.8% | -0.2% | 8.5% | Stock Analytics | |
| CHOLAMANDALAM FINANCIAL HOLDINGS | ₹24,074.9 Cr | 3.5% | 14.8% | 48.2% | Stock Analytics | |
| IIFL FINANCE | ₹19,839.1 Cr | -4.1% | 18.9% | 0.3% | Stock Analytics | |
| AUTHUM INVESTMENT & INFRASTRUCTURE | ₹19,012.5 Cr | 8.3% | 31.3% | 241.9% | Stock Analytics | |
| CAPRI GLOBAL CAPITAL | ₹18,614.8 Cr | 5.3% | 0.1% | 12% | Stock Analytics | |
ARUNJYOTI BIO VENTURES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ARUNJYOTI BIO VENTURES | 8.6% |
1.5% |
142.7% |
| SENSEX | 0.4% |
5.5% |
22.9% |
You may also like the below Video Courses
